Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

This grant supports research on the development of monoclonal antibodies to prevent and treat infections caused by Flaviviruses, such as Dengue Virus, Tick-borne Encephalitis Virus, Japanese Encephalitis Virus, West Nile Fever Virus, Yellow Fever Virus, and Zika Virus. The aim is to expand prophylactic and therapeutic options, strengthen preparedness for future infectious disease outbreaks, and reinforce the EU’s leading role in research and innovation related to health security.

AgencyHORIZON (EU)
RegionEUUSAother
CountryN/A
Legal formCompany, NGO, Government organization, Other
Start date10 Feb 2027
End date13 Apr 2027
Max fundingEUR 9,000,000 - 10,000,000 per project
BudgetEUR 37,300,000 (2027 call total budget)
Coverage

Funding rate: up to 100% of eligible costs for eligible applicants